EUVIMEDEUVIMED entdecken
Crossref

Design, Hemisynthesis, Computational, and Biological Evaluation of Novel Totarol‐1,3‐Thiazol Derivatives as Anticancer Agents

Ayoub Boualli iD, Mourad Fawzi, Yassine Laamari, Lubna Tahtamouni iD, Sultan Erkan, Abdelkhalek Riahi, Anthony Robert, My Youssef Ait Itto, Aziz Auhmani iD

Chemical Biology & Drug Design · 2026-04 · 107 (4)

DOI: 10.1111/cbdd.70288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 12.04.2026. Verfasst von Ayoub Boualli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Chemistry, Unit of Organic Synthesis and Molecular Physico-Chemistry, Department of Chemistry, Faculty of Sciences Semlalia, …. Hauptthemen laut MEDLINE: Thiazoles, Thiosemicarbazones, Caspase 8, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current study reports the design and synthesis of novel totarol‐based 1,3‐thiazole derivatives DBT 2 ‐ 9 and evaluates their anticancer potential. The synthesis involved the reaction of totarol derivatives with thiosemicarbazone derivatives under optimized conditions. Structural characterization of the synthesized compounds was accomplished using high‐resolution mass spectrometry (HRMS), infrared spectroscopy (IR), and nuclear magnetic resonance (NMR) spectroscopy, confirming their chemical identities and purity. The antitumor activity of these compounds was evaluated using the in vitro MTT and apoptosis assays. The compounds demonstrated selective anti‐proliferative effects against MCF‐7 breast cancer cells, and compound DBT 9 had an IC 50 value comparable to those of reference anticancer drugs. By activating caspases 4 and 8, which mediate the stress‐mediated and extrinsic apoptosis pathways, respectively, compound DBT 9 caused MCF‐7 cell death. Furthermore, density functional theory (DFT) was carried out to study the electronic properties and the chemical reactivity of the synthesized compounds. Furthermore, molecular docking studies revealed that DBT 9 displayed the highest binding affinity toward multiple cancer‐associated target proteins, including EGFR, VEGFR‐2, and FGFR1. These findings indicate that DBT 9 showed the best cytotoxic activity through the induction of apoptosis via caspase 4 and 8 pathways, indicating its potential as a promising bioactive compound.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiazolesThiosemicarbazonesCaspase 8Antineoplastic AgentsMagnetic Resonance SpectroscopyApoptosisDrug Screening Assays, AntitumorStructure-Activity RelationshipMolecular Docking SimulationHumansCaspases, Initiator

Stichwörter der Autor:innen

1,3‐ThiazoleDFTanticancer activityapoptosiscaspasesmolecular dockingtotarol

Substanzen

ThiazolesThiosemicarbazonesCaspase 8CASP4 protein, humanAntineoplastic AgentsCaspases, Initiator

Autor:innen und Institutionen

  • Laboratory of Molecular Chemistry, Unit of Organic Synthesis and Molecular Physico-Chemistry, Department of Chemistry, Faculty of Sciences Semlalia, Université Cadi Ayyad, Marrakech, Morocco.
  • Laboratory of Computer Science and Interdisciplinary Physics, ENS, Sidi Mohamed Ben Abdellah University, Fez, Morocco.
  • Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa, Jordan.
  • Department of Biochemistry and Molecular Biology, College of Natural Sciences, Colorado State University, Fort Collins, Colorado, USA.
  • Department of Chemistry, Faculty of Science, Sivas Cumhuriyet University, Sivas, Turkey.
  • Institut de Chimie Moléculaire de Reims, CNRS UMR 7312 Bat. Europol'Agro-Moulin de la Housse UFR Sciences, Reims, France.

ORCID-Profile: Ayoub Boualli, Lubna Tahtamouni, Aziz Auhmani

Zitieren

APA

Boualli, A., Fawzi, M., Laamari, Y., Tahtamouni, L., Erkan, S., Riahi, A., Robert, A., Ait Itto, M. Y., & Auhmani, A. (2026). Design, Hemisynthesis, Computational, and Biological Evaluation of Novel Totarol‐1,3‐Thiazol Derivatives as Anticancer Agents. Chemical Biology & Drug Design, 107(4). https://doi.org/10.1111/cbdd.70288

Vancouver

Boualli A, Fawzi M, Laamari Y, Tahtamouni L, Erkan S, Riahi A, et al. Design, Hemisynthesis, Computational, and Biological Evaluation of Novel Totarol‐1,3‐Thiazol Derivatives as Anticancer Agents. Chemical Biology & Drug Design. 2026;107(4). doi:10.1111/cbdd.70288

BibTeX
@article{Boualli2026,
  author = {Boualli, Ayoub and Fawzi, Mourad and Laamari, Yassine and Tahtamouni, Lubna and Erkan, Sultan and Riahi, Abdelkhalek and Robert, Anthony and Ait Itto, My Youssef and Auhmani, Aziz},
  title = {Design, Hemisynthesis, Computational, and Biological Evaluation of Novel Totarol‐1,3‐Thiazol Derivatives as Anticancer Agents},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {107},
  number = {4},
  doi = {10.1111/cbdd.70288}
}
Kostenlos starten →